Fluorescence microscopic examination of filipin-stained cultured skin fibroblasts derived from two brothers with group D Niemann-Pick disease revealed abnor- 
Between 1914 and 1927, Niemann (1) and Pick (2) correlated a series of clinical cases of progressive central nervous system deterioration and hepatosplenomegaly into a distinct disease entity. This inborn metabolic disorder came to be known as Niemann-Pick disease and was shown by Klenk (3) in 1934 to be associated' with elevated tissue levels of sphingomyelin. The The metabolic bases of the group A and group B NiemannPick disorders was established in 1966 to represent gross failure of normal sphingomyelin catabolism due to a specific primary deficiency in lysosomal sphingomyelinase activity (5) (6) (7) . The primary metabolic lesion(s) of the Niemann-Pick variant disorders (groups C and D; NP-C and NP-D) have yet to be defined. Moderate visceral storage of sphingomyelin and inconsistent documentation of sphingomyelinase deficiencies have led to the conclusion that sphmigomyelin storage is not the primary metabolic basis of NP-C (8) . A similar conclusion had previously been reached concerning NP-D disease (9) .
The documentation of a primary cholesterol-storage disorder in a mutant strain of BALB/c mice, (10, 11) was instrumental in the subsequent discovery that NP.C patients also manifested abnormal patterns of intracellular cholesterol processing in cultured cells developed from these individuals (8, (12) (13) (14) Cell Culture Techniques. Cell lines were maintained in Eagle's minimal essential medium with 10% (vol/vol) complete fetal bovine serum, 2 mM L-glutamine, 100 units of penicillin per ml, and 100 ,ug of streptomycin per ml, in humidified 95% air/5% CO2 at 37TC. Cells were harvested by washing monolayers three times with phosphate-buffered saline and subsequently treating the cell layers with 0.05% trypsin (Worthington) for 5 min at 370C before final cell washing and centrifugation.
Lipid Analysis. Fibroblast cell pellets were suspended in 250 ,u of 2-propanol and briefly sonicated with a microprobe.
The 2-propanol extract was incubated at 37°C for 30 min and subsequently centrifuged at 3000 x g 10 min. The 2-propanol extract was utilized for lipid measurements, and cell pellets were dissolved in 250 ,1 of 0. (17) . In the absence of an exogenous lipoprotein source, control and NP-D fibroblasts developed little fluorescent staining (Fig. 1) . When nonconfluent cells were incubated with LDL (100 ,g/ml) for 24 hr, NP-D fibroblasts developed a strikingly more intense fluorescence than that seen in normal cultures. This suggested that, in contrast to a normal cellular response, the NP-D cells were primarily accumulating LDL-derived cholesterol as unesterifled cholesterol that was localized within inclusion bodies. Similar findings have been reported for NP-C cell lines (12) . The increase in plasma membrane filipin staining in normal fibroblasts incubated with LDL suggests that unesterified cholesterol increased in these plasma membranes. The absence of increased staining of NP-D fibroblast plasma membranes suggests that unesterified cholesterol was not released from lysosomal inclusions and consequently was not available for entry into the plasma membrane cholesterol pool.
Mass Measurements of Cellular Cholesterol. The accumulation of LDL-cholesterol by confluent cell cultures was significantly higher in NP-C cells when compared to NP-D and control fibroblasts (Fig. 2) (18) .
Levels of cholesterol acyltransferase (acyl-CoA:cholesterol O-acyltransferase, EC 2.3.1.26) activity in cell-free extracts of fibroblasts incubated with LDL (50 ,ug/ml) for 24 hr were in the normal range (1000 ± 300 pmol of cholesteryl (14); (iii) excessive accumulation of LDL-derived cholesterol in mutant cells (14) ; and (iv) a delay in the initiation of LDL-receptor down-regulation and cholesterol acyltransferase activation in mutant cells (19) . These metabolic errors in NP-C mutant fibroblasts appear to be closely linked to abnormal lysosomal trapping of exogenously derived cholesterol. The widely divergent geographical origins and diverse clinical presentations of the Niemann-Pick variant disorders suggest the possibility that these diseases may represent a series of specific genotypic subtypes. The availability of fibroblasts from a confirmed NP-D family presented an opportunity to begin to examine this particular mutant for possible errors in cholesterol processing. Fibroblasts derived from clinically affected male children of this family were found to be grossly deficient in their ability to esterify cholesterol derived from LDL and nonlipoprotein sources. The heterozygous mutant cell culture obtained from an obligate carrier was partially deficient in esterification of LDL-cholesterol. The homozygous mutant NP-D cell cultures accumulated LDL-derived cholesterol primarily as unesterified cholesterol. No deficiency of cholesterol acyltransferase activity was seen in cell-free extracts of NP-D fibroblasts. The deficiency of the NP-D cells in initiating normal cholesterol ester synthesis parallels a similar pattern of blocked cholesterol esterification observed in NP-C fibroblasts.
One notable feature of abnormal cholesterol processing common to NP-C cells was, however, not noted with the NP-D cells under comparable culture conditions. Incubation with LDL caused confluent NP-C fibroblast cultures to accumulate excessive intracellular cholesterol that was 2-to 3-fold greater than normal. Similarly treated confluent cultures of NP-D cells did not manifest the excessive uptake of the lipoprotein-derived cholesterol observed with NP-C cells. A lesion in the esterification of internalized cholesterol, but not in the regulation of LDL-cholesterol uptake, was also seen in fibroblasts derived from the mutant cholesterolstorage mouse. Although the molecular basis of this murine disorder remains to be identified, the primary mutation has been shown to be closely linked to a lesion in esterification of exogenously derived cholesterol (13) . The similar profiles of abnormal cholesterol processing in the mutant mouse and human NP-D cells encourage further comparative studies.
The appearance of apparent varying expressions of abnormal cellular cholesterol processing in the NP-C and NP-D cells suggests that genotypically distinct lesions may exist within the family of Niemann-Pick variant disorders that disrupt specific segments of the cholesterol homeostatic pathway. Further elucidation of this possibility will have to await a detailed examination of the reactions involved in intracellular cholesterol processing.
